I think regulation happens at many levels. From a university perspective, getting clinical trial approval through an ethics board at a university is difficult. It's compounded by the fact that in Canada we don't have harmonized ethics board approval at the universities. As a result, if you have a multiplayer project--and we have researchers at Laval, Guelph, and Toronto--each of those researchers has to get approval from a separate ethics board.
Then we work with Health Canada. The problem with Health Canada is not Health Canada, it's that our researchers are not engaging Health Canada regulators early in the system. Once they've gone through their trials, they then go to Health Canada and ask for approval. Then Health Canada has to go through a learning process.